|
Volumn 12, Issue 2, 1986, Pages 153-166
|
Hodgkin's disease: Is there a price for successful treatment? A 25-year experience
a a a a |
Author keywords
Actuarial risk; Hodgkin's disease; SMN; Survival
|
Indexed keywords
BLEOMYCIN;
CHLORMETHINE;
CYCLOPHOSPHAMIDE;
DACARBAZINE;
DOXORUBICIN;
PREDNISONE;
PROCARBAZINE;
VINBLASTINE;
VINCRISTINE;
VINCRISTINE SULFATE;
ADVERSE DRUG REACTION;
BLOOD AND HEMOPOIETIC SYSTEM;
CANCER CHEMOTHERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CARCINOGENESIS;
CLINICAL ARTICLE;
HODGKIN DISEASE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
PRIORITY JOURNAL;
RADIOTHERAPY;
STATISTICAL ANALYSIS;
SURVIVAL;
THERAPY;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DRUG THERAPY;
FOLLOW-UP STUDIES;
HODGKIN DISEASE;
HUMAN;
NEOPLASMS;
RADIOTHERAPY;
RISK;
STATISTICS;
TIME FACTORS;
|
EID: 0022636033
PISSN: 03603016
EISSN: None
Source Type: Journal
DOI: 10.1016/0360-3016(86)90088-X Document Type: Article |
Times cited : (36)
|
References (28)
|